Tata Chemicals Limited

Tata Chemicals Limited

TATACHEM.NS
Tata Chemicals LimitedIN flagNational Stock Exchange of India
710.40
INR
-8.20
- -
180.98BMarket Cap
Tata Chemicals Limited
TATACHEM.NS
(National Stock Exchange of India)

Recent

price

710.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
441.81
424.64
477.31
521.9
548.38
522.87
406.12
399.64
402.73
402.44
396.02
491.33
654.74
600.65
579.97
565.1
580.92
Revenue per Share
33.79
32.88
15.72
-40.51
23.41
30.25
38.98
95.51
45.37
275.02
10.06
49.38
90.95
10.52
9.22
-74.42
13.21
Basic EPS, GAAP
13.48
16.51
-15.89
64.18
26.22
64.47
113.27
43.96
19.59
22.79
31.22
14.45
54.68
46.4
-9.58
2.51
- -
Free Cash Flow per Basic Share
15.65
12.54
11.91
11.62
11.88
14.99
11.99
13.2
26.4
15.01
11.01
10.01
12.52
17.55
14.99
10.99
- -
Dividend per Share
3.85
130.84
131.17
76.56
33.04
49.1
69.23
191.59
213.84
252.81
255.5
308.96
386.13
373.42
374.24
294.5
- -
Book Value per Share
7.53
14.95
10.73
-22.35
16.84
15.65
68.7
196.75
235.03
143.74
216.76
364.62
396.93
491.25
459.69
483.26
- -
Tangible Book Value per Share
250
255
255
255
255
255
255
255
255
255
255
255
255
255
255
255
255
Basic Weighted Avg Shares
110,606
108,179
121,599
132,957
139,703
133,204
103,461
101,810
102,599
102,524
100,888
125,170
166,800
153,020
147,750
143,970
148,170
Sales/Revenue/Turnover
12.86
17.26
14.93
9.53
13.58
12.42
15.53
16.67
12.06
12.8
7.64
12.29
17.93
12.66
5.63
4.21
6.06
Operating Margin (%)
4,467
5,087
5,339
4,712
4,631
5,714
5,524
5,306
5,714
6,665
7,593
8,060
8,920
9,800
11,230
12,010
11,300
Depreciation Expense
8,460
8,376
4,004
-10,320
5,965
7,706
9,931
24,331
11,559
70,063
2,564
12,580
23,170
2,680
2,350
-18,960
3,370
Net Income, GAAP
24.53
24.86
33.13
- -
30.31
21.04
23.59
3.71
19.09
17.6
31.19
16.02
10.51
45.9
32.05
- -
19.12
Effective Tax Rate (%)
7.65
7.74
3.29
-7.76
4.27
5.78
9.6
23.9
11.27
68.34
2.54
10.05
13.89
1.75
1.59
-13.17
2.27
Profit Margin (%)
9,199
12,162
12,874
22,172
15,602
25,538
17,690
53,362
41,497
7,740
21,824
16,490
32,600
3,120
5,810
4,630
- -
Working Capital
49,163
54,845
54,610
68,831
57,595
67,797
43,610
53,940
47,829
36,614
53,881
38,600
56,770
32,890
48,160
53,770
- -
LT Debt
58,581
67,844
69,497
62,207
90,618
94,528
105,321
138,189
152,559
136,614
151,426
191,570
206,420
231,140
225,010
221,750
- -
Total Equity
10.2
11.32
8.34
- -
8
7.08
6.78
8.67
4.83
5.04
2.43
5.34
10.07
3.77
1.95
- -
- -
Return on Invested Capital (%)
19.43
11.17
4.13
- -
5.82
6.32
8.26
19.17
8.29
47.63
1.87
8.65
15.16
2.02
2.42
- -
-0.11
Return on Capital (%)
66.27
48.84
12
-39
42.72
73.65
65.89
73.23
22.38
117.87
3.96
17.5
26.17
2.77
2.47
-22.26
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
ST Debt
- -
22,560
- -
LT Borrowings
- -
41,660
- -
LT Finance Leases
- -
6,500
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
255
- -
Market Capitalization
268,102
220,574
238,903

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
Total Current Assets
- -
67,200
- -
Cash, Cash Equivalents & STI
- -
14,010
- -
Accounts Receivable, Net
- -
19,000
- -
Inventories
- -
25,580
- -
Total Current Liabilities
- -
61,390
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
22,560
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.56%
8.43%
-1.45%
Free Cash Flow
-2.48%
-7.44%
-126.23%
Net Income, GAAP
-0.15%
-106.53%
-906.81%
Sales/Revenue/Turnover
1.82%
8.61%
-2.56%
Total Cash Common Dividend
3.52%
2.99%
-26.7%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
42,180
39,980
37,300
33,560
153,020
2025
37,890
39,990
35,900
35,090
147,750
2026
37,190
35,500
34,380
- -
143,970

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
20.88
16.8
6.2
- -
10.52
2025
5.89
7.61
-2.08
-2.19
9.22
2026
9.89
-3.65
-83.68
- -
-74.42

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
17.55
2025
- -
- -
- -
- -
14.99
2026
- -
- -
- -
- -
10.99
Business
Tata Chemicals Limited manufactures and markets basic and specialty chemistry products worldwide. The company produces soda ash in dense, heavy, high purity, industrial grade, and light varieties; sodium bicarbonate; salt including livestock, dry industrial, and Tata Shudh branded varieties; caustic soda; chlorine and bromine-based products; gypsum; calcium chloride; crushed refined soda; standard ash Magadi; crex; energy products; ordinary Portland and masonry cement; specialty silica; nano zinc oxide; prebiotics and dietary fibers such as FOS; agrochemicals including herbicides, insecticides, fungicides, bio-fertilizers, bio-stimulants, micronutrients, organic fertilizers, water-soluble fertilizers, bio-pesticides; and seeds through its listed subsidiary Rallis India Limited. It operates manufacturing facilities in India at Mithapur, Ankleshwar, Dahej in Gujarat; Cuddalore in Tamil Nadu; Mambattu in Andhra Pradesh; Lote and Akola in Maharashtra; the UK at Winnington, Lostock, and Middlewich; the US in Wyoming's Green River Basin; and Kenya at Magadi, serving customers in over 99 countries across the Indian subcontinent, Southeast Asia, Middle East, Africa, Europe, the UK, Americas, Asia, and Oceania in industries such as glass, detergents, food and nutrition, pharmaceuticals, agriculture, animal nutrition, construction, high performance rubber, metals, oral care and cosmetics, paints, inks, adhesives, soaps, textiles, leather, and batteries. Founded in 1939 and headquartered in Mumbai, India, as part of the Tata Group, the company maintains R&D centres including the TCL Innovation Centre in Pune and Rallis facilities in Bengaluru. Recent developments include a November 2025 board approval for Rs 910 crore capex to expand dense soda ash capacity by 350 KTPA at Mithapur over 24 months and precipitated silica capacity by 50 KTPA at Cuddalore over 27 months to meet demand in sustainability, tyre, and rubber applications; a Rs 655 crore investment by Tata Chemicals Europe for pharmaceutical-grade sodium bicarbonate expansion starting construction in 2025; and the October 2025 launch of ChemForce, a Salesforce-powered AI CRM platform to enhance customer engagement in India.